000			02992cam a2200349 a 4500
003			EG-GiCUC
005			20250223031717.0
008			170429s2016 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.28.Ph.D.2016.Ya.I
100	0		_aYasmin Saied Aly
245	1	0	_aInhaled versus intravenous magnesium sulphate in critically Ill infants and children with wheezy chest / _bYasmin Saied Aly ; Supervised Hala Hamdy Shaaban , Hafez Mahmoud Bazaraa , Hanaa Ibrahim Rady
246	1	5	_aسلفات المغنيسيوم بالاستنشاق او عن طريق الوريد لعلاح الحالات الحرجة المصحوبة بضيق الشعب الهوائية فى الاطفال
260			_aCairo : _bYasmin Saied Aly , _c2016
300			_a210 P. : _bcharts ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics
520			_aWheezy chest remains one of the major causes for emergency department visits and admissions at pediatric intensive care units (PICUs). We aimed to determine the efficacy of magnesium sulfate (MgSo4) versus standard treatment in critically ill infants and children with wheezy chest. A randomized controlled trial comprised 81 patients suffering from wheezy chest divided into 3 groups. In addition to bronchodilators and systemic steroids, MgSo4 was given by inhalation in group A, intravenously in group B, and group C didn't receive MgSo4. The improvement in our cases was determined by clinical respiratory score (CRS), ventilator setting and arterial blood gases before and after treatment. Median age was 11 months, mean weight 9.3kg and the median of SOFA score was one. After treatment: There was significant improvement of CRS, respiratory rate and air entry in the three groups. Significant improvement in intercostals and subcostal retraction, mental state in group A and B; (p=0.03/0.002, p=0.0003/0.032; respectively). In group A, there was significant reduction in ventilator rate (p=0.017) and improvement of arterial/inspired oxygen ratio (p=0.0056). In group B, significant improvement in the color of the patients (p=0.0005) and a better mean arterial pH was noted (p=0.009). No significant rise in serum magnesium level. The median duration of oxygen supply and PICU stay was higher in group C compared to A and B. Magnesium sulfate is a safe and beneficial adjuvant therapy in addition to standard treatment in critically ill infants and children with wheezy chest
530			_aIssued also as CD
653		4	_aCritically ill infants and children
653		4	_aInhaled Mgso4
653		4	_aIV Mgso4
700	0		_aHafez Mahmoud Bazaraa , _eSupervisor
700	0		_aHala Hamdy Shaaban , _eSupervisor
700	0		_aHanaa Ibrahim Rady , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c60710 _d60710